Edgestream Partners L.P. Invests $3.97 Million in Molina Healthcare, Inc $MOH

Edgestream Partners L.P. purchased a new position in Molina Healthcare, Inc (NYSE:MOHFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 13,318 shares of the company’s stock, valued at approximately $3,967,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MOH. Price T Rowe Associates Inc. MD raised its holdings in Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after acquiring an additional 1,216,903 shares during the last quarter. Norges Bank acquired a new stake in shares of Molina Healthcare in the second quarter valued at approximately $212,113,000. AQR Capital Management LLC lifted its position in Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after buying an additional 264,664 shares in the last quarter. Fiera Capital Corp acquired a new position in Molina Healthcare during the second quarter worth $42,644,000. Finally, Nuveen LLC purchased a new stake in Molina Healthcare in the 1st quarter valued at $46,441,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Sanford C. Bernstein reduced their price target on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a report on Friday, September 5th. UBS Group reduced their target price on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating on the stock in a research note on Friday, October 24th. Wells Fargo & Company decreased their target price on shares of Molina Healthcare from $231.00 to $165.00 and set an “overweight” rating on the stock in a report on Wednesday, November 12th. Deutsche Bank Aktiengesellschaft set a $165.00 price target on shares of Molina Healthcare in a report on Friday, October 24th. Finally, TD Cowen cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $203.00 price objective on the stock. in a report on Thursday, October 16th. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Molina Healthcare has an average rating of “Hold” and an average target price of $198.93.

View Our Latest Report on MOH

Molina Healthcare Price Performance

Molina Healthcare stock opened at $149.11 on Thursday. The company’s 50 day simple moving average is $166.81 and its 200-day simple moving average is $203.25. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.68 and a current ratio of 1.68. Molina Healthcare, Inc has a 1 year low of $133.40 and a 1 year high of $359.97. The company has a market capitalization of $8.08 billion, a price-to-earnings ratio of 9.23 and a beta of 0.52.

Molina Healthcare (NYSE:MOHGet Free Report) last posted its earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($2.13). The company had revenue of $11.48 billion during the quarter, compared to analyst estimates of $10.99 billion. Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business posted $6.01 EPS. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, equities research analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the business’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the sale, the director owned 11,352 shares in the company, valued at approximately $1,623,563.04. The trade was a 3.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.26% of the company’s stock.

Molina Healthcare Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

See Also

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOHFree Report).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.